Vivelle Dot
Product Images NDC 54868-4243

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Vivelle Dot (NDC 54868-4243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 0.05 mg Package Label (4242)

This is a description of a medical product called VIVELLE-DOT TRNSDR, which is distributed by PHYSICIANS TOTAL CARE. The product is a patch that contains 0.85mg of medication and there are 8 patches in one package (NDC 54868-4242-0). The lot number is 0000 and the expiration date is 01/60. The rest of the text is not legible.*

FDA Label Image

Image Of 0.75 mg Package Label (4243)

This is a medication product called VIVELLE-DOT TRHSDR 6.075 HG PAT, distributed by PHYSICIANS TOTAL CARE with a National Drug Code (NDC) of 54868-4243-0. The package contains 8 units and a lot number which is followed by an expiration date. The last line with the number "42430080000" is not clear and it is difficult to determine its meaning or relevance to the product description.*

FDA Label Image

Image Of 0.1 mg Package Label (4244)

Vivelle-Dot Transdermal System is distributed by Physicians Total Care and has an NDC 54868-4244-6. The medication is in the form of a patch containing 0.11g and has a Lot No. of 000, with an expiration date of 01/60. The remaining text is not clear to form a complete description.*

FDA Label Image

Image Of 0.0375 mg Package Label (4920)

This is a description of a pack of eight VIVELLE-DOT TRNSDR 8. 6375 PAT hormone patches, distributed by PHYSICIANS TOTAL CARE. The NDC (National Drug Code) is 54868-4920-0 and the lot number is ¥ 0008 with the expiration date of 01/60. The rest of the text seems to be unreadable and contains non-English characters.*

FDA Label Image

Estradiol Structural Formula (Vivelle Dot 02)

FDA Label Image

Vivelle-dot Layer Image (Vivelle Dot 03)

FDA Label Image

Figure 1steady State Estradiol Plasma Concentrations For Systems Applied To The Abdomennonbaseline Corrected Levels (Vivelle Dot 04)

FDA Label Image

Figure 2 Mean (sd) Change From Baseline In Mean Daily Number Of Flushes For Vivelle® 0.0375 mg Versus Placebo In A 12 Week Trial. (Vivelle Dot 05)

FDA Label Image

Figure 3 Bone Mineral Density Ap Lumbar Spine Least Squares Means Of Percentage Change From Baseline All Randomized Patients With At Least One Post Baseline Assessment Available With Last Post Baseline Observation Carried Forward (Vivelle Dot 06)

This is a table showing the percentage change from baseline in a treatment duration for different doses of Vivelle, which is a medication available in several strengths measured in milligrams per day. The data is presented for three different points in time: Week 52, Week 78, and Week 104. There are five different strength options, including a placebo.*

FDA Label Image

Figure 4 Bone Mineral Density Femoral Neck Least Squares Means Of Percentage Change From Baseline All Randomized Patients With At Least One Post Baseline Assessment Available With Last Post Baseline Observation Carried Forward (Vivelle Dot 07)

FDA Label Image

Determine Your Schedule For Your Twice-a-week Application (Vivelle Dot 08)

FDA Label Image

Where To Apply Vivelle-dot® (Vivelle Dot 09)

FDA Label Image

Before You Apply Vivelle-dot® (Vivelle Dot 0a)

FDA Label Image

How To Apply Vivelle-dot® 1 (Vivelle Dot 0b)

FDA Label Image

How To Apply Vivelle-dot® 2 (Vivelle Dot 0c)

FDA Label Image

How To Apply Vivelle-dot® 3 (Vivelle Dot 0d)

FDA Label Image

How To Apply Vivelle-dot® 4 (Vivelle Dot 0e)

FDA Label Image

How To Apply Vivelle-dot® 5 (Vivelle Dot 0f)

FDA Label Image

How To Apply Vivelle-dot® 6 (Vivelle Dot 10)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.